The authors reply Journal Article

  

Authors:	Wolchok, J. D.; Rollin, L.; Larkin, J.
Article Title:	The authors reply
Keywords:	cancer survival; treatment response; gene mutation; cancer combination chemotherapy; drug safety; drug withdrawal; monotherapy; unspecified side effect; letter; ipilimumab; melanoma; clinical decision making; b raf kinase; braf gene; nivolumab; human; priority journal
Journal Title:	New England Journal of Medicine
Volume:	377
Issue:	25
ISSN:	0028-4793
Publisher:	Massachusetts Medical Society
Date Published:	2017-12-21
Start Page:	2503
End Page:	2504
Language:	English
DOI:	10.1056/NEJMc1714339
PROVIDER:	scopus
PUBMED:	29262279
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85039797210&doi=10.1056%2fNEJMc1714339&partnerID=40&md5=2881dcdebd3386ed5982fa93108a545b
Notes:	Letter -- Export Date: 1 February 2018 -- Source: Scopus